Table 1—

Maternal and neonatal descriptions of normal-weight, late LGA, and early LGA infants of women with type 1 diabetes

Birth weight
P*
NormalLate LGAEarly LGA
n1199
Maternal descriptions
    Maternal age (years)35.8 ± 3.634.9 ± 4.234.1 ± 4.60.669
    Prepregnancy BMI (kg/m2)24.0 ± 3.926.7 ± 7.825.4 ± 3.80.695
    Insulin administration (MIT/CSII)6/55/45/40.992
    Duration of diabetes (years)9.6 ± 9.516.3 ± 9.219.1 ± 8.50.126
    Age of onset of diabetes (years)26.1 ± 11.118.6 ± 10.015.0 ± 7.40.136
    Type of insulin: human/analog9/25/44/50.221
    White classification: B/C/D/F7/1/2/13/4/1/11/5/2/10.101
A1C level (%)
    Trimester 16.2 ± 0.56.1 ± 0.47.0 ± 0.90.019
    Trimester 26.2 ± 0.56.1 ± 0.46.7 ± 0.50.045
    Trimester 36.1 ± 0.56.2 ± 0.57.0 ± 0.70.012
Neonatal descriptions
    Male/female5/65/44/50.845
    Gestational age at birth38.2 ± 1.238.9 ± 1.637.2 ± 1.10.090
    Birth weight2,946 ± 4543,994 ± 1814,239 ± 173
    Birth weight centile42 ± 2295 ± 398 ± 0.1
Hypoglycemia (yes/no)5/66/35/30.672
  • Data are means ± SD or n unless otherwise indicated.

  • * Significant difference between any of the groups with P < 0.05.

  • Different by definition and therefore not included in the analysis. CSII, continuous subcutaneous insulin infusion; MIT, multiple injection therapy.